| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |